EHC Stock Recent News
EHC LATEST HEADLINES
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health (EHC) remains well-poised for growth on the back of an active expansion strategy and sufficient cash-generating abilities.
The inpatient rehabilitation hospital's opening in Fitchburg, WI, was moved up from the initially scheduled first quarter of 2024.
Encompass Health (EHC) opens an inpatient rehabilitation hospital in Prosper to address the diversified needs of the greater Dallas area residents. It marks EHC's 160th nationwide facility.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health (EHC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Encompass Health Corporation (NYSE:EHC ) Q3 2023 Results Conference Call October 27, 2023 10:00 AM ET Company Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President, CEO Doug Coltharp - CFO Conference Call Participants A.J. Rice - UBS Ann Hynes - Mizuho Securities Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Matt Larew - William Blair Kieran Ryan - Deutsche Bank Operator Good morning, everyone and welcome to Encompass Health's Third Quarter 2023 Earnings Conference Call.
Encompass Health's (EHC) Q3 results benefit from an increase in patient volumes and net patient revenue per discharge. Management currently projects adjusted EPS to be within $3.41-$3.52 for 2023.
While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.